Rare diseases
Investigational molecules
Locations
Back to Germany5 clinical trials in Wipperfuerth, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on inflammatory bowel disease (IBD), specifically studying both Crohn's disease and ulcerative colitis. Multiple trials are evaluating novel therapeutic approaches for moderate to severe cases.
Studies aim to improve patient outcomes through innovative treatment combinations and extended therapy evaluations.
Dedicated research exploring new treatments for Crohn's disease, including studies of mirikizumab and other innovative compounds. Trials focus on achieving endoscopic response and clinical remission.
Research emphasizes both short-term therapeutic responses and sustained treatment benefits.
Advanced clinical research examining combination therapies for ulcerative colitis, including pioneering work with guselkumab and golimumab combination treatments.
Investigations focus on comparing combined treatments with traditional monotherapy approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
